VHT ETF Analysis: Health Care Shares | NYSE

Healthcare Equity | NYSE, USA | Market Cap: 20.963m USD | 12M Return: 29% | US92204A5048 | Charts, Fundamentals & Technical Analysis

Pharmaceuticals, Biotechnology, Medical Devices, Health Insurance
Total Rating 75
Safety 73
Buy Signal 0.55
Healthcare Equity
Category Rotation: +2.5
TER: 0.10%
AUM: 21.0B
Avg Turnover: 95.6M
Risk 3d forecast
Volatility20.6%
VaR 5th Pctl3.55%
VaR vs Median-4.18%
Reward TTM
Sharpe Ratio1.39
Rel. Str. IBD84.3
Rel. Str. Peer Group45.2 pctl
Character TTM
Beta0.218
Beta Downside0.191
Hurst Exponent0.468
Choppyness48.6%
Drawdowns 3y
Max DD16.91%
CAGR/Max DD0.97
CAGR/Mean DD3.37

Warnings

No concerns identified

Tailwinds

Supp Ema8

Seasonality 11.7 years of data

Jan +0.1% 16
Feb -0.9% 18
Mar -1.2% 29
Apr +0.2% 2
May -0.1% 7
Jun +0.9% 18
Jul +0.9% 28
Aug +0.0% 5
Sep -1.4% 32
Oct -2.6% 12
Nov +4.8% 44
Dec -0.3% 13

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: VHT Health Care Shares

The Vanguard Health Care Index Fund ETF (VHT) is a passively managed exchange-traded fund that seeks to mirror the performance of a benchmark index composed of U.S. companies of all market capitalizations operating in the health care sector. Stocks are classified as health care under the Global Industry Classification Standard (GICS), the industry taxonomy jointly maintained by S&P Dow Jones Indices and MSCI. The fund uses a full replication strategy, holding each constituent stock in approximately the same weight as in the underlying index. Despite the broad health care universe, the fund is classified as non-diversified.

The GICS health care sector encompasses subsectors such as pharmaceuticals, biotechnology, medical devices, health care equipment and supplies, and health care providers and services. As an ETF listed on the NYSE, VHT trades throughout the day at market prices and was launched in January 2004.

Headlines to Watch Out For
  • Aging demographics drive sustained healthcare demand growth
  • Drug pricing reform legislation pressures sector margins
  • GLP-1 obesity drug sales boost top holdings
What is the price of VHT shares?

As of November 11, 2026, the stock is trading at USD 348.81 with a total of 190,986 shares traded. Over the past week, the price has changed by +2.35%, over one month by +8.78%, over three months by +10.47% and over the past year by +28.98%.

Current recommended Stop Loss: 332.10 (which is 4.8% or 2.6 ATR below the current price).

Is VHT a buy, sell or hold?

Health Care Shares has no consensus analysts rating.